Episodic Migraine

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA label_change · 2025-06-19
FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in changes to the product labeling.